Role of eIF3a in regulating cisplatin sensitivity and in translational control of nucleotide excision repair of nasopharyngeal carcinoma.
about
Adenovirus-mediated delivery of interferon-γ gene inhibits the growth of nasopharyngeal carcinomaTranslational regulation of RPA2 via internal ribosomal entry site and by eIF3aN-myc downstream regulated 1 (NDRG1) is regulated by eukaryotic initiation factor 3a (eIF3a) during cellular stress caused by iron depletion.The prognostic value of altered eIF3a and its association with p27 in non-small cell lung cancers.Downregulation of Ras association domain family member 6 (RASSF6) underlies the treatment resistance of highly metastatic nasopharyngeal carcinoma cells.Host age is a systemic regulator of gene expression impacting cancer progressionHigh expression of XPA confers poor prognosis for nasopharyngeal carcinoma patients treated with platinum-based chemoradiotherapyOverexpression of eIF3a in Squamous Cell Carcinoma of the Oral Cavity and Its Putative Relation to Chemotherapy Response.Upregulated Expression of SOX4 Is Associated with Tumor Growth and Metastasis in Nasopharyngeal Carcinoma.Exploring the key genes and signaling transduction pathways related to the survival time of glioblastoma multiforme patients by a novel survival analysis model.Targeting Jab1/CSN5 in nasopharyngeal carcinomaeIF3a improve cisplatin sensitivity in ovarian cancer by regulating XPC and p27Kip1 translation.Suppression of Jab1/CSN5 induces radio- and chemo-sensitivity in nasopharyngeal carcinoma through changes to the DNA damage and repair pathwaysSpectrin domain of eukaryotic initiation factor 3a is the docking site for formation of the a:b:i:g subcomplex.Overexpression of asparagine synthetase and matrix metalloproteinase 19 confers cisplatin sensitivity in nasopharyngeal carcinoma cells.Antitumor efficacy of a recombinant adenovirus encoding endostatin combined with an E1B55KD-deficient adenovirus in gastric cancer cells.FASN regulates cellular response to genotoxic treatments by increasing PARP-1 expression and DNA repair activity via NF-κB and SP1TXNL1-XRCC1 pathway regulates cisplatin-induced cell death and contributes to resistance in human gastric cancer.BEX3 contributes to cisplatin chemoresistance in nasopharyngeal carcinoma.EIF3i promotes colon oncogenesis by regulating COX-2 protein synthesis and β-catenin activation.Human ABCG2: structure, function, and its role in multidrug resistance.BST2 confers cisplatin resistance via NF-κB signaling in nasopharyngeal cancer.Downregulation of lncRNA ANRIL represses tumorigenicity and enhances cisplatin-induced cytotoxicity via regulating microRNA let-7a in nasopharyngeal carcinoma.Tumor-specific cytolysis caused by an E1B55K-attenuated adenovirus in nasopharyngeal carcinoma is augmented by cisplatin.Regulation of protein translation initiation in response to ionizing radiation.MiR-629 promotes human pancreatic cancer progression by targeting FOXO3.ARHGEF19 interacts with BRAF to activate MAPK signaling during the tumorigenesis of non-small cell lung cancer.Differential response to doxorubicin in breast cancer subtypes simulated by a microfluidic tumor model.eIF3 Regulation of Protein Synthesis, Tumorigenesis, and Therapeutic Response.eIF3: a factor for human health and disease.XPA expression is a predictive marker of the effectiveness of neoadjuvant chemotherapy for locally advanced uterine cervical cancer.Molecular characterization and integrative genomic analysis of a panel of newly established penile cancer cell lines.Elevated serum LAMC2 is associated with lymph node metastasis and predicts poor prognosis in penile squamous cell carcinoma
P2860
Q34526425-10EA3D9D-1B97-448A-8857-A318771EA83AQ34580793-AB849EE7-548D-4168-80DA-DE56D1F0DEBCQ34600331-F7E1C03C-D89E-456D-BC54-524EC18ABA87Q35161905-98B8082C-6377-4482-A00D-E99835ABD79BQ35207555-BB0182D9-F543-47D8-BFC1-81BF825EDBF2Q35428467-BA1DD16C-637E-4B36-BEAB-1B521F5EC71EQ35686424-4B85FA1B-7FE8-48E9-9EC3-86B5CB12B1FFQ35944966-E5B68417-7C15-4A94-BE01-04DC923D6934Q36249545-8293F0BF-9EE3-4FAC-8572-FB1A5307392AQ36280795-8C625160-7E4A-40AB-823B-084AB9B0E9F4Q36327912-BACCCBB0-ECAF-478C-BA97-5450DFDF5EB6Q36413207-88813851-E156-4CC9-A235-1C75B10D785AQ36592296-80D5F096-1F0D-499A-8C83-3D5C144DBD15Q37201229-EEF498A8-CFB7-4B91-A74A-8D4806B1A976Q37227757-A2C883EF-63BF-43BC-9766-B7C15F2D6281Q37370299-1802D97B-E7AC-435B-8C4B-0835BF0A14C3Q37417939-4EFA6B11-2F1A-452E-9A8C-19328E7610A1Q37620658-0BEB59A3-C968-4BDE-B9A9-EECD107A6A16Q37648125-9D9EDAE3-837B-4DA8-818B-0D0C646150DBQ37656530-00A0A4FB-2CA2-4DAA-A62D-33D33779CC02Q38003156-C10DC7AE-017B-41C0-9BAA-277F5DAB20E4Q38700288-333EB8D3-617D-49CC-A41C-8BF5311BDA22Q39002027-A391A1B0-9D79-4CE0-8ECB-2145562D3E05Q42261523-7CDAB8E1-50BB-4F43-8E63-0533D7DE0E73Q42271914-28D317AA-D8EC-417D-B0EE-39C315951F06Q46037722-B06EF7D0-FD44-4DA3-BEA9-154FF9D4358AQ47375003-6391E6AA-3BC2-4883-965E-EA47EE0A6E9AQ47645697-A6B7B195-2E58-4817-91E7-A64034BDAC71Q51334042-FA9B56EE-5C3E-4555-969B-AFDBFD2A00E0Q52445969-B97D5AA8-63DE-4FD5-8C15-B6B36ABB75B3Q53700829-6173D070-8587-4DDC-B725-76D65D7967F0Q55185781-E32CC152-13B9-4DBD-B797-6369A0FF49FDQ58698566-0A2F7D0C-7707-4423-8343-44215CAE6F59
P2860
Role of eIF3a in regulating cisplatin sensitivity and in translational control of nucleotide excision repair of nasopharyngeal carcinoma.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Role of eIF3a in regulating ci ...... r of nasopharyngeal carcinoma.
@ast
Role of eIF3a in regulating ci ...... r of nasopharyngeal carcinoma.
@en
type
label
Role of eIF3a in regulating ci ...... r of nasopharyngeal carcinoma.
@ast
Role of eIF3a in regulating ci ...... r of nasopharyngeal carcinoma.
@en
prefLabel
Role of eIF3a in regulating ci ...... r of nasopharyngeal carcinoma.
@ast
Role of eIF3a in regulating ci ...... r of nasopharyngeal carcinoma.
@en
P2093
P2860
P356
P1433
P1476
Role of eIF3a in regulating ci ...... r of nasopharyngeal carcinoma.
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2011.189
P407
P50
P577
2011-05-30T00:00:00Z
P5875
P6179
1008461877